Nicotine: all 173 studies that test it
Page 2 of 2. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.
- The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose NicotineWithdrawnNCT03281694Phase 1
- Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy SmokersCompletedNCT03235505Phase 4
- The Effect of Nicotine Delivery Rate on ReinforcementCompletedNCT03134339Early Phase 1
- Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT IIWithdrawnNCT02942212Early Phase 1
- Control Systems Approach to Predicting Individualized Dynamics of Nicotine CravingsStatus unknownNCT02643914Not applicable
- The Use of Nicotine Patches Together With E-cigarettes (With and Without Nicotine) for Smoking CessationCompletedNCT02521662Phase 3
- Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and CigaretteCompletedNCT02511704Phase 1
- Transdermal Nicotine Replacement in Smokers With Acute Aneurysmal Subarachnoid HemorrhageCompletedNCT02350335Not applicable
- Effect of Nicotine on Brain Reward PathwaysCompletedNCT02346539Phase 1
- Effect of Smoking Reduction on Endothelial Glucocalyx and Vascular FunctionStatus unknownNCT02307045Phase 4
- Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1CompletedNCT02179034Phase 1
- Electronic Cigarettes in Daily Dependent SmokersCompletedNCT02108626Phase 4
- Neural Mechanisms Underlying Nicotine and Alcohol CombinationsCompletedNCT02049268Not applicable
- Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in HumansCompletedNCT02018263Phase 1
- Very Low-Nicotine Cigarettes in Smokers With SUDCompletedNCT01989507Phase 2
- Association of Functional COMT Val108/Met Polymorphism With Smoking Cessation in Nicotine Replacement TherapyCompletedNCT01980550Phase 4
- Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke ExposureCompletedNCT01935713Not applicable
- Novel Methods to Reduce Children's Secondhand Smoke Exposure IICompletedNCT01896518Not applicable
- Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine LozengeCompletedNCT01887847Phase 1
- Sublingual Nicotine Tablets Compared With Swedish SnusCompletedNCT01838460Phase 1/2
- Reducing Cardiovascular Disease by Combining Smoking Cessation Pharmacotherapy and Behavioural CounselingCompletedNCT01623505Phase 4
- Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug EffectWithdrawnNCT01589081Not applicable
- Effects of Progesterone on IV Nicotine Induced Changes on BOLD fMRI Signal, Hormones and Subjective Ratings of Stimulant DrugsWithdrawnNCT01589068Not applicable
- IV Nicotine Induced Changes in Hormone Function, Mood States and BehaviorWithdrawnNCT01589055Not applicable
- Clinical Trial to Evaluate the Efficacy of Smoking CessationCompletedNCT01538394Phase 4
- An Exploratory Study Comparing Two Nicotine InhalersCompletedNCT01478230Early Phase 1
- Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With SchizophreniaTerminatedNCT01465074Not applicable
- A Study on the Effects of Two Nicotine Replacement Products on Tooth StainingCompletedNCT01440985Not applicable
- Galantamine Effects on Nicotine Responses in SmokersCompletedNCT01417429Phase 1
- Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine GumCompletedNCT01368016Not applicable
- Effects of Contingency Management and Nicotine Replacement Therapy on Youth SmokingCompletedNCT01359709Phase 1
- Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement ProductsCompletedNCT01321931Phase 1
- Single-dose Pharmacokinetics of Oral Nicotine Replacement ProductsCompletedNCT01228617Not applicable
- 4 mg Nicotine Polacrilex Gum and Swedish Portion SnusCompletedNCT01182129Phase 1/2
- Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152749Not applicable
- Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152736Not applicable
- Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® GumCompletedNCT01152723Not applicable
- Assessing Top Down and Bottom Up Attention Mechanisms in Smokers Using Nicotine Nasal SprayCompletedNCT01136642Phase 1
- Bioequivalence Between Nicotine Replacement Products and Nicorette® GumCompletedNCT01113424Not applicable
- Nicotine Patch Trial in Syrian Primary Care SettingsCompletedNCT01085032Phase 2
- Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ LozengeCompletedNCT01075659Phase 2
- Effects of Nicotine on Elements of Attentions in Smokers and NonsmokersCompletedNCT01034020Phase 1
- The Safety of Transdermal Nicotine Immediately Following an Acute Coronary SyndromeSuspendedNCT00990197Not applicable
- Sensitivity to Intravenous Nicotine: Genetic ModeratorsCompletedNCT00969137Phase 1
- Varenicline Versus Transdermal Nicotine Patch for Smoking Cessation in Patients With Coronary Heart DiseaseCompletedNCT00959972Phase 4
- Study of NP002 in Subjects With Idiopathic Parkinson's Disease to Treat Dyskinesias Due to Levodopa TherapyCompletedNCT00957918Phase 1/2
- Nicotine Patch, Blood Flow and Oxidative Stress StudyCompletedNCT00954096Not applicable
- Efficacy and Safety Following Use of a Novel Nicotine Replacement TherapyCompletedNCT00882375Not applicable
- Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's DiseaseCompletedNCT00873392Phase 2
- Effect of Smoking, Abstention and Nicotine Replacement Therapy on Wound HealingCompletedNCT00825851Not applicable
- Preemptive Use of the Nicotine Patch for Postoperative Pain Relief After Open Abdominal SurgeryTerminatedNCT00790829Not applicable
- Transdermal Nicotine in Female Patients at High Risk for Post Operative Nausea and/or Vomiting (PONV)WithdrawnNCT00775749Not applicable
- Clinical Study of Smoke-Break Liquid CigarettesCompletedNCT00715871Phase 2
- Nicotinic Modulation of Schizophrenia-like Information Processing Deficits in Healthy SubjectsCompletedNCT00690170Phase 1
- Interactive Psychopharmacologic Effects of Alcohol and Nicotine in HumansCompletedNCT00616746Early Phase 1
- Study of Nicotine for the Prevention of PONVTerminatedNCT00553709Phase 2
- Effect Of Nicotine on Neurocognitive Performance of Cigarette SmokersStatus unknownNCT00429208Not applicable
- Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By CancerWithdrawnNCT00425906Not applicable
- The Effects of Nicotine Withdrawal on Reward Responsivity in SchizophreniaCompletedNCT00373126Phase 4
- Nicotine Replacement Therapy for Smoking Cessation in SchizophreniaCompletedNCT00320723Phase 4
- Strategies to Help Adult ED Patients Quit SmokingCompletedNCT00297466Not applicable
- Nicotine Skin Patch in Treating Patients With Kaposi's SarcomaCompletedNCT00295984Phase 2
- Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With SchizophreniaCompletedNCT00218218Phase 2
- Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1CompletedNCT00218140Phase 2
- Examining the Effectiveness of the Nicotine Patch in Male and Female Smokers - 2CompletedNCT00135746Not applicable
- Impact of Smoking Cessation on Sleep - 5CompletedNCT00132821Phase 4
- Nicotine Replacement Treatment for Pregnant Smokers - 1TerminatedNCT00115687Phase 2
- Nicotine Treatment of Mild Cognitive Impairment (MCI)Status unknownNCT00091468Phase 1
- Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1CompletedNCT00067158Phase 3
- Tobacco Cessation in Postmenopausal Women (Part II) - 2CompletedNCT00061074Phase 1
- Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of SmokingCompletedNCT00033592Phase 3
- Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop SmokingCompletedNCT00021138Not applicable
- Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage CancerCompletedNCT00002520Not applicable